Without urgent change, this Aussie MD is warning that pharma companies will increasingly decide not to bring medicines here

Several thousand life sciences professionals voted for the companies they most wanted to work at. See who topped the list

Who has a new Country Medical Director? Plus other job appointments as industry looks to bed down teams for 2026

ICYMI: More Aussie pharma jobs go as another company downsizes plus the other most popular stories this week

It's nowhere near the most expensive acquisition this year but this buyout could create the next generation of oral cancer treatments

New white paper launched by ARCS urges workforce system reform to keep Australia a top-tier clinical trials destination

Despite axing 9000 jobs, the impact locally has been limited although the exact number of Aussie jobs gone remains undisclosed

Australian employees have joined a gruelling cycle across Japan to raise funds and awareness for bowel cancer

After a rival ended a deal with a small pharma developing an antiviral biologic for flu, looks who's stepped in with a buyout offer

More HCPs and patients are seeing the value in telehealth, with a third expecting it to be their main healthcare by 2030

One pharma surpassed all others at CHP Australia's annual awards night, with eight companies hitting the stage to be recognised

Search is on for local scientific innovators working in vaccines, immunotherapies and related techs to take to commercialisation

PBAC's Public Summary Documents shed light on why MSD's bid for a multi-cancer listing for Keytruda got the thumbs down

Brands currently enjoying exclusivity are watching more companies register generic versions

As its battle to be bought by Cosette enters its closing days, Mayne is receiving other offers for its assets, and good news from the FDA

Australia becomes the 40th country to fund this drug as a first-line treatment option for these multiple myeloma patients

Arrotex steps in to fill a gap created by the discontinuation of two brands of hypertension drug in Australia

Transformed his company into a global powerhouse while staying true to its core values of scientific excellence and patient-centred care